Nanjing Baidier Biopharmaceutical Co., Ltd.

News

Home page

Company Express

Medical dynamics

CDE

Meternet

Cooperation with Yangzijiang Pharmaceutical

Release time:

2023-09-18 17:20

User evaluation and comments:

Nanjing Baidier Biopharmaceutical Co., Ltd. will transfer the development technology of nanalidomide raw materials and capsules to our company in the future. The technology is mature, stable and reliable in quality. After our company has transferred the raw material development technology and capsule development technology of this product, we have completed further industrial scale-up production on this basis, successfully completed multiple batches of verification production, successfully passed the bioequivalence study, and obtained the production number in July 2020. This technology transformation has realized the key process from development to production, and has played a very important role in the quality and listing of our products. On September 18, the company sold the first box of lenalidomide capsules (Youjia) produced by Yangzijiang Pharmaceutical Group Co., Ltd., from landing to successful listing.

None